Literature DB >> 28885034

Treatment outcomes of Class II malocclusion cases treated with miniscrew-anchored Forsus Fatigue Resistant Device: A randomized controlled trial.

Osama Eissa, Mahmoud El-Shennawy, Safaa Gaballah, Ghada El-Meehy, Tarek El Bialy.   

Abstract

OBJECTIVE: To evaluate the skeletal, dental, and soft tissue effects of the Forsus Fatigue Resistant Device (FRD) used with miniscrew anchorage and compare them with those of the conventional Forsus FRD.
MATERIALS AND METHODS: This study was carried out on 38 patients. These patients were randomly allocated into three groups. The 14 patients in group 1 (aged 12.76 ± 1.0 years) were treated with the FRD appliance. In group 2, the 15 patients (aged 12.52 ± 1.12 years) received treatment with FRD using miniscrew anchorage, and the 9 patients in group 3 (aged 12.82 ± 0.9 years) received no treatment as a control group. Linear and angular measurements were made on lateral cephalograms before and immediately after Forsus treatment. Data were analyzed statistically using paired t-, ANOVA, and Tukey tests.
RESULTS: Class I molar relationship and overjet correction were achieved in both treatment groups. Although mandibular growth was statistically nonsignificant, there was a significant headgear effect on the maxilla. Mandibular incisor proclination, maxillary incisor retroclination, and distalization of maxillary molars were significant in both treatment groups. However, no significant differences were found between the treatment groups.
CONCLUSIONS: Class II correction was mainly dentoalveolar in both treatment groups. Use of miniscrews with Forsus did not enhance mandibular forward growth nor prevent labial tipping of the mandibular incisors.

Entities:  

Keywords:  Class II malocclusion; Fixed functional appliance; Forsus; Miniscrew

Mesh:

Year:  2017        PMID: 28885034     DOI: 10.2319/032717-214.1

Source DB:  PubMed          Journal:  Angle Orthod        ISSN: 0003-3219            Impact factor:   2.079


  7 in total

1.  Treatment of Class III malocclusion using miniscrew-anchored inverted Forsus FRD: Controlled clinical trial.

Authors:  Osama Eissa; Mahmoud ElShennawy; Safaa Gaballah; Ghada ElMehy; Tarek El-Bialy
Journal:  Angle Orthod       Date:  2018-06-18       Impact factor: 2.079

Review 2.  A Scoping Review about the Characteristics and Success-Failure Rates of Temporary Anchorage Devices in Orthodontics.

Authors:  Daniel Jaramillo-Bedoya; Gustavo Villegas-Giraldo; Andrés A Agudelo-Suárez; Diana Milena Ramírez-Ossa
Journal:  Dent J (Basel)       Date:  2022-05-06

3.  Treatment efficiency of activator and skeletal anchored Forsus Fatigue Resistant Device appliances.

Authors:  Sinem Ince-Bingol; Burcak Kaya; Burak Bayram; Ayca Arman-Ozcirpici
Journal:  Clin Oral Investig       Date:  2020-07-15       Impact factor: 3.573

4.  A comparison of the effects of Forsus appliances with and without temporary anchorage devices for skeletal Class II malocclusion.

Authors:  Lu Liu; Qi Zhan; Jing Zhou; Qianyun Kuang; Xinyu Yan; Xiaoqi Zhang; Yue Shan; Wenli Lai; Hu Long
Journal:  Angle Orthod       Date:  2021-03-01       Impact factor: 2.079

Review 5.  Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents.

Authors:  Klaus Bsl Batista; Badri Thiruvenkatachari; Jayne E Harrison; Kevin D O'Brien
Journal:  Cochrane Database Syst Rev       Date:  2018-03-13

6.  Skeletal and dentoalveolar effects of class II malocclusion treatment using bi-maxillary skeletal anchorage: a systematic review.

Authors:  Maged S Alhammadi; Amal Abdulsalam A Qasem; Aisha Mohammed S Yamani; Rawan Duhduh A Duhduh; Rahaf T Alshahrani; Esam Halboub; Abeer A Almashraqi
Journal:  BMC Oral Health       Date:  2022-08-10       Impact factor: 3.747

7.  Role of anatomical sites and correlated risk factors on the survival of orthodontic miniscrew implants: a systematic review and meta-analysis.

Authors:  Hisham Mohammed; Khaled Wafaie; Mumen Z Rizk; Mohammed Almuzian; Rami Sosly; David R Bearn
Journal:  Prog Orthod       Date:  2018-09-24       Impact factor: 2.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.